The AVONELLE-X study confirms sustained visual gains and treatment durability of faricimab for wet AMD over four years. 80% ...
The ACTOR study finds OCT angiography cannot predict exudative recurrence in neovascular AMD but offers valuable vascular ...
Following the assembly of the prototype, the OCT researchers were able to present the first high-resolution images of the eye ...
Kala Bio announced that CHASE (NCT05727878), its phase 2b clinical trial of KPI-012 for persistent corneal epithelial defect ...
Explore the Fight Retinal Blindness! Project, a global registry enhancing VEGF inhibitor treatment outcomes with ...
Explore how digital image management and AI transform ophthalmology, enhancing diagnostics and personalizing patient care in retina practices.
“Pattern recognition is key,” emphasized Prem S. Subramanian, MD, PhD, as he discussed the challenges of distinguishing ...
Can you share some highlights from the BETTER study with us? Marion Munk, MD, PhD: I'm very excited about this project. We ...
Smith highlights advances in interventional glaucoma, including first-line SLT, emerging surgical options, and co-management strategies, during the Ophthalmology Times and Optometry Times EyeCon 2025 ...
Canadian medical device company MacuMira Medical Devices recently introduced the first Health Canada-approved treatment to ...
The recipients of this year’s Visionary in Eye Care Resident Recognition Awards were revealed at the Ophthalmology Times and Optometry Times EyeCon® 2025 conference, held September 26 and 27 at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback